These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 2427844

  • 1. Celiprolol in the treatment of exercise induced angina pectoris.
    Capone P, Mayol R.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S135-7. PubMed ID: 2427844
    [Abstract] [Full Text] [Related]

  • 2. Celiprolol in angina pectoris: a controlled study.
    Eff J, Godfrey J, Garutti R, Capone P.
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S132-4. PubMed ID: 2427843
    [Abstract] [Full Text] [Related]

  • 3. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH, Heiman M, Soberman J, Greenberg S, Eff J.
    Am J Cardiol; 1991 Apr 01; 67(8):665-70. PubMed ID: 1672481
    [Abstract] [Full Text] [Related]

  • 4. Atenolol and celiprolol for stable angina pectoris.
    McLenachan JM, Findlay IN, Henderson E, Wilson JT, Dargie HJ.
    Am J Cardiol; 1988 Feb 10; 61(5):52C. PubMed ID: 2893533
    [Abstract] [Full Text] [Related]

  • 5. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ, Low RI, Paumer L, Amsterdam EA, Mason DT.
    Am J Cardiol; 1983 Jan 01; 51(1):13-8. PubMed ID: 6129794
    [Abstract] [Full Text] [Related]

  • 6. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H, McLenachan JM, Wilson JT.
    J Int Med Res; 1988 Jan 01; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [Abstract] [Full Text] [Related]

  • 7. [Celiprolol in the treatment of chronic stable angina].
    Román O, Cuevas G, Martínez D, Vargas W.
    Rev Med Chil; 1991 Jan 01; 119(1):50-5. PubMed ID: 1688095
    [Abstract] [Full Text] [Related]

  • 8. A double blind placebo controlled study of celiprolol in the treatment of angina pectoris.
    Harston WE, Eff J, Capone P.
    Br J Clin Pract Suppl; 1985 Jun 01; 40():55-8. PubMed ID: 2864066
    [No Abstract] [Full Text] [Related]

  • 9. [A comparative study of celiprolol and nicardipine in stable angina of effort].
    Prohías Martínez JA, Chaple M, Rivero-Varona MM, Hernández-Acosta K, Toruncha-Chukram A, García-Barreto D.
    Arch Inst Cardiol Mex; 1991 Jun 01; 61(4):345-9. PubMed ID: 1683217
    [Abstract] [Full Text] [Related]

  • 10. Anti-ischemic effects of celiprolol in patients with exercise-induced angina pectoris.
    Douard H, Koch M, Laporte T, Abella ML, Provendier O, Broustet JP.
    Int J Cardiol; 1989 Oct 01; 25(1):63-8. PubMed ID: 2571590
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W, Fluch N, Brandt D.
    Wien Klin Wochenschr; 1982 May 14; 94(10):258-61. PubMed ID: 6126961
    [Abstract] [Full Text] [Related]

  • 13. A placebo-controlled double-blind multicenter study of celiprolol in the treatment of mild and moderate hypertension.
    Capone P, Mayol R.
    J Cardiovasc Pharmacol; 1986 May 14; 8 Suppl 4():S119-21. PubMed ID: 2427840
    [Abstract] [Full Text] [Related]

  • 14. Celiprolol in angina pectoris.
    Soberman JE, Frishman WH.
    Am Heart J; 1988 Nov 14; 116(5 Pt 2):1422-5. PubMed ID: 2903653
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of bevantolol for chronic, stable angina pectoris.
    Bowles MJ, Khurmi NS, O'Hara MJ, Raftery EB.
    Am J Cardiol; 1986 Nov 26; 58(12):28E-34E. PubMed ID: 2878598
    [Abstract] [Full Text] [Related]

  • 16. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
    Salonen JT, Taskinen E, Salonen R, Seppänen K, Venäläinen J, Rauramaa R.
    Am J Cardiol; 1986 Nov 26; 58(12):35E-40E. PubMed ID: 2878600
    [Abstract] [Full Text] [Related]

  • 17. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
    Faulhaber HD, Weigmann I, Lang U, Weinsberg F, Terhaag B.
    Int J Clin Pharmacol Ther; 2005 Feb 26; 43(2):63-70. PubMed ID: 15726874
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Angina, ischemia, and effort tolerance with vasodilating beta-blockers.
    Dargie HJ, Grant S, McLenachan J.
    Am Heart J; 1991 Mar 26; 121(3 Pt 2):1017-20. PubMed ID: 1671726
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.